Cite
OR31-2 Effects of Colchicine on Insulin Resistance, Pancreatic Beta-Cell Function, and Aspects of the Metabolic Syndrome (MetS) in Adults with Obesity, MetS, and Inflammation: A Pilot Randomized Controlled Trial
MLA
Sheila M. Brady, et al. “OR31-2 Effects of Colchicine on Insulin Resistance, Pancreatic Beta-Cell Function, and Aspects of the Metabolic Syndrome (MetS) in Adults with Obesity, MetS, and Inflammation: A Pilot Randomized Controlled Trial.” Journal of the Endocrine Society, vol. 3, Apr. 2019. EBSCOhost, widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=edsair&AN=edsair.doi.dedup.....fa646c900353d55da78af4dfa238822a&authtype=sso&custid=ns315887.
APA
Sheila M. Brady, Miranda M. Broadney, Jordan A. Levine, Jack A. Yanovski, & Andrew P. Demidowich. (2019). OR31-2 Effects of Colchicine on Insulin Resistance, Pancreatic Beta-Cell Function, and Aspects of the Metabolic Syndrome (MetS) in Adults with Obesity, MetS, and Inflammation: A Pilot Randomized Controlled Trial. Journal of the Endocrine Society, 3.
Chicago
Sheila M. Brady, Miranda M. Broadney, Jordan A. Levine, Jack A. Yanovski, and Andrew P. Demidowich. 2019. “OR31-2 Effects of Colchicine on Insulin Resistance, Pancreatic Beta-Cell Function, and Aspects of the Metabolic Syndrome (MetS) in Adults with Obesity, MetS, and Inflammation: A Pilot Randomized Controlled Trial.” Journal of the Endocrine Society 3 (April). http://widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=edsair&AN=edsair.doi.dedup.....fa646c900353d55da78af4dfa238822a&authtype=sso&custid=ns315887.